Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review

References

• National Comprehensive Cancer NetworkNCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain Version 22017 Available from: https://www.nccn.org/professionals/physician_gls/pdf/pain.pdfAccessed June 13, 2017
   Google Scholar
• van den Beuken-van EverdingenMHde RijkeJMKesselsAGSchoutenHCvan KleefMPatijnJPrevalence of pain in patients with cancer: a systematic review of the past 40 yearsAnn Oncol20071891437144917355955
   PubMed Web of Science ®Google Scholar
• PergolizziJVJrMercadanteSEchaburuAVThe role of trans-dermal buprenorphine in the treatment of cancer pain: an expert panel consensusCurr Med Res Opin20092561517152819435402
   PubMed Web of Science ®Google Scholar
• HigginsonIJMurtaghFCancer pain epidemiologyBrueraEDPortenoyRKCancer Pain Assessment and Management Second EditionNew YorkCambridge University Press20103752
   Google Scholar
• Te BoveldtNVernooij-DassenMBurgerNIjsseldijkMVissersKEngelsYPain and its interference with daily activities in medical oncology outpatientsPain Physician201316437938923877454
   PubMed Web of Science ®Google Scholar
• TemelJSJA GreerAMuzikanskyAEarly palliative care for patients with metastatic non-small-cell lung cancerN Engl J Med2010363873374220818875
   PubMed Web of Science ®Google Scholar
• RipamontiCISantiniDMaranzanoEManagement of cancer pain: ESMO Clinical Practice GuidelinesAnn Oncol201223suppl 7vii139vii15422997447
   PubMed Web of Science ®Google Scholar
• World Health Organization [webpage on the Internet]WHO’s Cancer Pain Ladder for Adults2017 Available from: www.who.int/cancer/palliative/painladder/enAccessed June 13, 2017
   Google Scholar
• CaraceniAHanksGKaasaSUse of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPCLancet Oncol2012132e58e6822300860
   PubMed Web of Science ®Google Scholar
• World Health OrganizationCancer Pain Relief (Second Edition) with a Guide to Opioid Availability1996 [cited Dec 22, 2016]; Available from: http://apps.who.int/iris/bitstream/10665/37896/1/9241544821.pdfAccessed June 13, 2017
   Google Scholar
• VithlaniRHBaranidharanGTransdermal opioids for cancer pain managementRev Pain2010428
   Google Scholar
• MercadanteSPathophysiology and treatment of opioid-related myoclonus in cancer patientsPain1998741599514554
   PubMed Web of Science ®Google Scholar
• BellTAnnunziataKLeslieJBOpioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness SurveyJ Opioid Manag20095313714419662923
   PubMedGoogle Scholar
• HolzerPAhmedzaiSHNiederleNOpioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its managementJ Opioid Manag20095314515119662924
   PubMedGoogle Scholar
• EstfanBMahmoudFShaheenPRespiratory function during parenteral opioid titration for cancer painPalliat Med2007212818617344255
   PubMed Web of Science ®Google Scholar
• VissersKCBesseKHansGDevulderJMorlionBOpioid rotation in the management of chronic pain: where is the evidence?Pain Pract2010102859320070552
   PubMed Web of Science ®Google Scholar
• ReddyAYennurajalingamSDesaiHThe opioid rotation ratio of hydrocodone to strong opioids in cancer patientsOncologist201419111186119325342316
   PubMed Web of Science ®Google Scholar
• CachiaEAhmedzaiSHTransdermal opioids for cancer painCurr Opin Support Palliat Care201151151921325999
   PubMedGoogle Scholar
• GuptaHBabuRTransdermal delivery: product and patent updateRecent Pat Drug Deliv Formul20137318420524025130
   PubMedGoogle Scholar
• PergolizziJAloisiAMDahanACurrent knowledge of buprenorphine and its unique pharmacological profilePain Pract201010542845020492579
   PubMed Web of Science ®Google Scholar
• KhannaIKPillarisettiSBuprenorphine – an attractive opioid with underutilized potential in treatment of chronic painJ Pain Res2015885987026672499
   PubMed Web of Science ®Google Scholar
• TrescotAMDattaSLeeMHansenHOpioid pharmacologyPain Physician2008112 supplS133S15318443637
   PubMed Web of Science ®Google Scholar
• MercadanteSVellucciRCuomoALong-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer painSupport Care Cancer20152351349135425351457
   PubMed Web of Science ®Google Scholar
• AurilioCPaceMPotaVOpioids switching with transdermal systems in chronic cancer painJ Exp Clin Cancer Res2009281119126230
   PubMed Web of Science ®Google Scholar
• HanksGWConnoFChernyNMorphine and alternative opioids in cancer pain: the EAPC recommendationsBr J Cancer200184558759311237376
   PubMed Web of Science ®Google Scholar
• UK NHSPosition Statement: Buprenorphine and Fentanyl Patches for Pain2015 Available from: http://www.lancsmmg.nhs.uk/download/position%20statements/Position%20Statement.%20Fentanyl%20&%20Buprenorphine%20Patches%20for%20Pain%20(Version%201.0).pdfAccessed June 13, 2017
   Google Scholar
• SkaerTLDosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer painJ Pain Res2014749525170278
   PubMed Web of Science ®Google Scholar
• KangKHKuoLFChengICChangCSTsayWITrends in major opioid analgesic consumption in Taiwan, 2002–2014J Formos Med Assoc2016 Epub 2016 Oct 4
   Web of Science ®Google Scholar
• van SeventerRSmitJMSchipperRMWicksMAZuurmondWWComparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate painCurr Med Res Opin200319645746914594516
   PubMed Web of Science ®Google Scholar
• HadleyGDerrySMooreRAWiffenPJTransdermal fentanyl for cancer painCochrane Database Syst Rev201310CD01027024096644
   PubMed Web of Science ®Google Scholar
• MelilliGSamolsky DekelBGFrenquelliCMelloneRPannutiFTransdermal opioids for cancer pain control in patients with renal impairmentJ Opioid Manag20141028524715663
   PubMedGoogle Scholar
• MercadanteSPorzioGFulfaroFSwitching from transdermal drugs: an observational “N of 1” study of fentanyl and buprenorphineJ Pain Symptom Manage200734553253817629666
   PubMed Web of Science ®Google Scholar
• SittlRLikarRNautrupBPEquipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort studyClin Ther200527222523715811486
   PubMed Web of Science ®Google Scholar
• SittlRNuijtenMNautrupBPChanges in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort studyClin Ther20052771022103116154481
   PubMed Web of Science ®Google Scholar
• SittlRNuijtenMNautrupBPPatterns of dosage changes with trans-dermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: a retrospective data analysis in GermanyClin Ther20062881144115416982291
   PubMed Web of Science ®Google Scholar
• AhmedzaiSBrooksDT-FCT GroupTransdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of lifeJ Pain Symptom Manage19971352542619185430
   PubMed Web of Science ®Google Scholar
• ApoloneGManganoSCompagnoniAA multidisciplinary project to improve the quality of cancer pain management in Italy: background, methods, and preliminary resultsJ Ambul Care Manage200629433234116985391
   PubMedGoogle Scholar
• KressHGVon der LaageDHoeraufKHA randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer painJ Pain Symptom Manage200836326827918538974
   PubMed Web of Science ®Google Scholar
• MercadanteSPorzioGFerreraPSustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain managementEur J Pain20081281040104618353696
   PubMed Web of Science ®Google Scholar
• WongJChiuGTsaoCChangCComparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer painActa Anaesthesiol Sin199735125329212478
   PubMedGoogle Scholar
• PayneRMathiasSDPastaDJQuality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphineJ Clin Oncol1998164158815939552070
   PubMed Web of Science ®Google Scholar
• CorliOMontanariMDeandreaSGrecoMTVillaniWApoloneGAn exploratory analysis on the effectiveness of four strong opioids in patients with cancer painPain Med201213789790722680789
   PubMed Web of Science ®Google Scholar
• MercadanteSValleAPorzioGOpioid switching in patients with advanced cancer followed at home. A retrospective analysisJ Pain Symptom Manage201345229830423102561
   PubMed Web of Science ®Google Scholar
• TassinariDSartoriSTamburiniEAdverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literatureJ Palliat Med200811349250118363493
   PubMed Web of Science ®Google Scholar
• FilitzJGriessingerNSittlRLikarRSchüttlerJKoppertWEffects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphineEur J Pain200610874374816426877
   PubMed Web of Science ®Google Scholar
• MercadanteSArcuriEOpioids and renal functionJ Pain20045121914975374
   PubMed Web of Science ®Google Scholar
• SittlRTransdermal buprenorphine in cancer pain and palliative carePalliat Med2006208 suppl253016482755
   PubMed Web of Science ®Google Scholar
• PloskerGLBuprenorphine 5, 10 and 20 mug/h transdermal patch: a review of its use in the management of chronic non-malignant painDrugs201171182491250922141389
   PubMed Web of Science ®Google Scholar
• TwycrossRGWilcockAPalliative Care Formulary4th edPalliativedrugs.com LtdNottingham, UK2011
   Google Scholar
• Health CanadaFentanyl transdermal patch and fatal adverse reactionsCan Adverse React Newsl2008181313
   Google Scholar
• FDA [webpage on the Internet]FDA Reminds the Public About the Potential for Life-Threatening Harm from Accidental Exposure to Fentanyl Transdermal Systems (“Patches”)2012 Available from: http://www.fda.gov/Drugs/DrugSafety/ucm300747.htmAccessed June 13, 2017
   Google Scholar
• JumbelicMIDeaths with transdermal fentanyl patchesAm J Forensic Med Pathol2010311182119918162
   PubMed Web of Science ®Google Scholar
• WalshSLPrestonKLBigelowGEStitzerMLAcute administration of buprenorphine in humans: partial agonist and blockade effectsJ Pharmacol Exp Ther199527413613727542336
   PubMed Web of Science ®Google Scholar
• DahanAYassenARombergRBuprenorphine induces ceiling in respiratory depression but not in analgesiaBr J Anaesth200696562763216547090
   PubMed Web of Science ®Google Scholar
• KressHGClinical update on the pharmacology, efficacy and safety of transdermal buprenorphineEur J Pain200913321923018567516
   PubMed Web of Science ®Google Scholar